Akèy › Kansè orofaringe › Minnesota › Rochester
Etid klinik pou Kansè orofaringe nan Rochester, MN
4 etid pou Kansè orofaringe ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Ap rekriteFaz 2
- Mayo Clinic in Rochester, Rochester
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Ap rekriteFaz 2
- Mayo Clinic in Rochester, Rochester
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- Mayo Clinic in Rochester, Rochester
Oropharynx (OPX) Biomarker Trial
Ap rekriteEtid obsèvasyon
- Mayo Clinic in Rochester, Rochester
Etid Kansè orofaringe nan lòt vil
- Atlanta, GA8 etid
- Edison, NJ8 etid
- Chicago, IL7 etid
- New York City, NY6 etid
- Queens, NY5 etid
- St. Louis, MO5 etid
- Tampa, FL5 etid
- Kansas City, MO5 etid
- Omaha, NE5 etid
- Philadelphia, PA5 etid
- Milwaukee, WI5 etid
- Los Angeles, CA5 etid
Lòt etid nan Rochester
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil37 etid
- Kansè Metastatik31 etid
- Kansè (tout kalite)30 etid
- Kansè ovè29 etid
- Kansè kolorektal29 etid
- Myelom Miltip24 etid
- Ensifizyans kadyak22 etid
- Kansè pwostat22 etid
- Kansè pankreyas22 etid
- Kansè Endomèt20 etid
- Kansè poumon20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.